Former Pharmacy President Adam Brosius Sentenced to 24 Months for $33M Healthcare Fraud and Kickback Scheme
Summary
Adam Brosius, 61, of Delray Beach, Florida, was sentenced to 24 months in prison on April 1, 2026 for his role in a $33 million health care fraud and kickback scheme involving compounded medications. Brosius and co-conspirators used Main Avenue Pharmacy, a mail-order pharmacy with a Clifton, New Jersey storefront, to distribute medically unnecessary scar creams, pain creams, migraine medication, and vitamins from 2014 through 2016. Brosius served as the pharmacy's director of business development before becoming its president.
“From 2014 through 2016, Brosius and others used Main Avenue Pharmacy, a mail-order pharmacy with a storefront in Clifton, New Jersey, to run an illegal kickback scheme involving medically unnecessary compounded drugs including scar creams, pain creams, migraine mediation, and vitamins.”
Pharmacies and healthcare providers should audit their compounded medication marketing practices and any referral-fee arrangements. Federal prosecutors secured convictions on both fraud and kickback charges, demonstrating parallel exposure under anti-kickback statutes even when the underlying scheme involves billable medications.
About this source
GovPing monitors US HHS OIG Enforcement for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 2 changes logged to date.
What changed
Adam Brosius, former president of Main Avenue Pharmacy, was sentenced to 24 months in federal prison for orchestrating a $33 million healthcare fraud and kickback scheme involving medically unnecessary compounded medications including scar creams, pain creams, migraine medication, and vitamins. The scheme operated from 2014 through 2016 using the mail-order pharmacy's Clifton, New Jersey storefront.
Healthcare providers, pharmacies, and pharmaceutical companies should review their compounded medication marketing and kickback arrangements for compliance with federal anti-kickback statutes. The substantial penalty—nearly $140,000 per month of the scheme—signals continued federal enforcement priority on healthcare fraud involving unnecessary prescription medications.
Penalties
24 months imprisonment
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Former Pharmacy President Sentenced to 24 Months in Prison for Health Care Fraud and Kickback Scheme Involving Compounded Medications
NEWARK, N.J. – On April 1, 2026 Adam Brosius, 61, of Delray Beach, Florida, was sentenced to 24 months in prison for his role in a $33 million health care fraud and kickback scheme, U.S. Attorney Robert Frazer announced. According to documents filed in this case and statements made in court: From 2014 through 2016, Brosius and others used Main Avenue Pharmacy, a mail-order pharmacy with a storefront in Clifton, New Jersey, to run an illegal kickback scheme involving medically unnecessary compounded drugs including scar creams, pain creams, migraine mediation, and vitamins. Brosius worked as Main Avenue’s director of business development, and later as its president.
Action Details
- Date: April 20, 2026
- Agency: U.S. Attorney's Office, District of New Jersey
- Enforcement Types:
- Criminal and Civil Actions
Parties
Related changes
Get daily alerts for US HHS OIG Enforcement
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from US DOJ.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when US HHS OIG Enforcement publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.